{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:58:17Z","timestamp":1789887497916,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["232301420060"],"award-info":[{"award-number":["232301420060"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["242300421086"],"award-info":[{"award-number":["242300421086"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073393"],"award-info":[{"award-number":["82073393"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["SBGJ202302023"],"award-info":[{"award-number":["SBGJ202302023"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.gendis.2025.101947","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:48:06Z","timestamp":1764089286000},"page":"101947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development"],"prefix":"10.1016","volume":"13","author":[{"given":"Zhihao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-2031","authenticated-orcid":false,"given":"Bing-Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gendis.2025.101947_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7689","key":"10.1016\/j.gendis.2025.101947_bib2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.gendis.2025.101947_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713618","article-title":"Targeted therapy for cancers: from ongoing clinical trials to FDA-approved drugs","volume":"24","author":"Choi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.gendis.2025.101947_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/cancers10070224","article-title":"Current molecular-targeted therapies in NSCLC and their mechanism of resistance","volume":"10","author":"Schrank","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.gendis.2025.101947_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188967","article-title":"20 years since the approval of first EGFR-TKI, gefitinib: insight and foresight","volume":"1878","author":"Singh","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s44178-024-00136-2","article-title":"Adjuvant therapy in resected non-small cell lung cancer: current status and perspectives","volume":"4","author":"Pirker","year":"2025","journal-title":"Holist Integr Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib7","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-03-0564","article-title":"United States food and drug administration drug approval summary: Gefitinib (ZD1839; Iressa) tablets","volume":"10","author":"Cohen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"suppl_1","key":"10.1016\/j.gendis.2025.101947_bib8","doi-asserted-by":"crossref","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","article-title":"Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors","volume":"29","author":"Westover","year":"2018","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cmet.2015.08.007","article-title":"PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer","volume":"22","author":"Dupuy","year":"2015","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41401-020-0465-8","article-title":"Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52","volume":"42","author":"Wang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib11","article-title":"PDK1 promotes breast cancer progression by enhancing the stability and transcriptional activity of HIF-1\u03b1","volume":"11","author":"Wei","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.gendis.2025.101947_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115166","article-title":"PKM2\/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism","volume":"249","author":"Lin","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.gendis.2025.101947_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrc4018","article-title":"Directly targeting transcriptional dysregulation in cancer","volume":"15","author":"Gonda","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101947_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3327","article-title":"Molecular mechanisms and potential functions of histone demethylases","volume":"13","author":"Kooistra","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.gendis.2025.101947_bib15","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tcb.2010.08.011","article-title":"Histone demethylases in development and disease","volume":"20","author":"Pedersen","year":"2010","journal-title":"Trends Cell Biol"},{"issue":"45","key":"10.1016\/j.gendis.2025.101947_bib16","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1038\/onc.2017.222","article-title":"Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation","volume":"36","author":"Nakatsuka","year":"2017","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.gendis.2025.101947_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.molcel.2019.09.019","article-title":"KDM3A senses oxygen availability to regulate PGC-1\u03b1-mediated mitochondrial biogenesis","volume":"76","author":"Qian","year":"2019","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/nar\/gku1298","article-title":"The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer","volume":"43","author":"Wade","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101947_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2023.01.006","article-title":"RNA m6A methylation across the transcriptome","volume":"83","author":"Sendinc","year":"2023","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","article-title":"The potential role of RNA N6-methyladenosine in cancer progression","volume":"19","author":"Wang","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","article-title":"Epigenetic modification of m6A regulator proteins in cancer","volume":"22","author":"Wang","year":"2023","journal-title":"Mol Cancer"},{"issue":"8","key":"10.1016\/j.gendis.2025.101947_bib23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/JTO.0000000000000569","article-title":"Total lesion glycolysis in positron emission tomography can predict gefitinib outcomes in non-small-cell lung cancer with activating EGFR mutation","volume":"10","author":"Keam","year":"2015","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41419-019-1524-2","article-title":"Lysine methylation of transcription factors in cancer","volume":"10","author":"Han","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gendis.2025.101947_bib25","article-title":"KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt\/\u03b2-catenin signalling","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.gendis.2025.101947_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m6A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.gendis.2025.101947_bib27","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.gendis.2025.101947_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101947_bib29","article-title":"Targeting cancer metabolism plasticity with JX06 nanoparticles via inhibiting PDK1 combined with metformin for endometrial cancer patients with diabetes","volume":"9","author":"Yang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.gendis.2025.101947_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.gendis.2025.101947_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00432-019-02847-w","article-title":"Prognostic role of glycolysis for cancer outcome: evidence from 86 studies","volume":"145","author":"Yu","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molcel.2006.12.010","article-title":"Dynamic regulation of histone lysine methylation by demethylases","volume":"25","author":"Shi","year":"2007","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2025.101947_bib35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","article-title":"mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification","volume":"118","author":"Kumari","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101947_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N6-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/15476286.2022.2096793","article-title":"Progress and application of epitranscriptomic m6A modification in gastric cancer","volume":"19","author":"Xu","year":"2022","journal-title":"RNA Biol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101947_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","article-title":"Insights into N6-methyladenosine and programmed cell death in cancer","volume":"21","author":"Liu","year":"2022","journal-title":"Mol Cancer"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225004362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:34:13Z","timestamp":1777304053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225004362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2352304225004362"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101947","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDK1 elevation was induced by epigenetic modifications of KDM3A and METTL16 to mediate TKI resistance and cancer development","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101947"}}